Clinical Trial Update: Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children [Phase 2]

View source ↗

Summary

This Phase 2 trial compared the bronchodilator CHF1535 inhaler with the free combination of beclometasone and formoterol inhalers in children with asthma, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclometasone/Formoterol (beclometasone/formoterol)
• CHF1535

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED